                                                5
        Abstract
        Vitamin medicine pyridine-3-formic      acid synthesis method, comprises the
   following steps: 3 mol 2-hydroxy-3-ethyl-4-aminopyridine       and 6-7 mol ethylene
 5 glycol monobutyl ether were added to the reaction vessel, controlled the stirring speed
   of 170-190 rpm, raised the temperature of the solution to 60-70 "C, then added 3-4
   mol of triethyl antimony in 3-6 times, raised the temperature of the solution to
   75-80 'C, kept for 50-70 min, precipitated the solid, washed with potassium bromide
   solution in 6-9 times, merged the filtrate and the washing liquid, the oxalic acid
10 solution was added to adjust the pH to 2-3, the solution temperature is reduced to
   5-9 'C, the solid is precipitated, washed with N-dimethylacetamide solution, and
   washed with the dimethylamine solution, recrystallized in p-cresol solution.

                                                   1
                   Vitamin medicine pyridine-3-formic acid synthesis method
         FIELD OF THE INVENTION
         The present invention relates to vitamin medicine pyridine-3-formic acid synthesis
 5 method.
         GENERAL BACKGROUND
         Pyridine-3-carboxylic acid is mainly used to promote the health of the digestive
   system, reduce gastrointestinal disorders, make the skin more healthy, prevent and
10 alleviate serious migraine, promote blood circulation, reduce blood pressure, reduce
   diarrhea, reduce meniere's disease of the symptoms; so that the body can make full use
   of food to increase energy; treatment of oral, lips inflammation; lower cholesterol and
   triglycerides, lack of disease, pellagra. However, most of the existing synthetic methods
   are using 3-methylpyridine as the reactant, it is complicated and the final yield is not
15 very high. Therefore, it is necessary to propose a new synthetic method for further
   improving the quality and yield of the product and reducing the byproduct content, it
   has important economic significance.
         SUMMARY
20       The purpose of the present          invention  is to provide vitamin       medicine
   pyridine-3-formic acid synthesis method, comprises the following steps:
         (i) 3 mol 2-hydroxy-3-ethyl-4-aminopyridine        and 6-7 mol ethylene glycol
   monobutyl ether were added to the reaction vessel, controlled the stirring speed of
   170-190 rpm, raised the temperature of the solution to 60-70 'C, then added 3-4 mol of
25 triethyl antimony in 3-6 times, raised the temperature of the solution to 75-80 "C, kept
   for 50-70 min, precipitated the solid, washed with potassium bromide solution in 6-9
   times, merged the filtrate and the washing liquid, the oxalic acid solution was added to
   adjust the pH to 2-3, the solution temperature is reduced to 5-9 0C, the solid is
   precipitated, washed with N-dimethylacetamide solution, and washed with the
30 dimethylamine solution, recrystallized in p-cresol solution; wherein, the mass fraction

                                                  2
   of the ethylene glycol monobutyl ether solution in step (i) is 80-87% and the mass
   fraction of the potassium bromide described in step (i) is 20-26%, the mass fraction of
   the oxalic acid solution in step (i)         is 30-35%,       the mass  fraction  of the
   N-dimethylacetamide solution in step (i) is 70 to 77%, the mass fraction of the
 5 dimethylamine solution described in step (i) is 85 to 91%, the mass fraction of p-cresol
   solution in step (i) is 90-96%.
         Throughout the reaction process can be the following reaction formula:
             NH2
                       CH2CH3                                                       COOH
                           GH2H3   C6H 14 0 2 + C6 H15Sb      -OO
             N         OH                                                   N
10       Advantage of the present invention is that: reducing intermediate links reaction,
   decreasing the reaction time and improving the reaction yield.
         DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
         The following examples with reference to specific embodiments of the present
15 invention are further illustrated:
         vitamin medicine pyridine-3-formic acid synthesis method.
         Embodiment 1
         The reaction vessel were added 3 mol 2-hydroxy-3-ethyl-4-aminopyridine and 6
20 mol ethylene glycol monobutyl ether with a mass fraction of 80%, controlled the
   stirring speed at 170 rpm, raised the solution temperature to 60 'C, and then added 3
   mol triethyl antimony 3 times, raised the temperature of the solution to 75 C for 50 min,
   precipitated the solid, washed with the potassium bromide solution with a mass fraction
   of 20% in 6 times, combined filtrate and washing liquid, added the oxalic acid solution
25 with a mass fraction of 30% to adjust the pH to 2, reduced the solution temperature to
   5'C, precipitated the solid, washed with the N-dimethyl acetamide solution with a
   mass fraction of 70%, washed with the dimethyl amine solution with a mass fraction of

                                                  3
   85%, recrystallizated in the p-cresol solution with a mass fraction of 90%, dehydrated
   with dehydration, got the finished pyridine-3-carboxylic acid 339.48g, yield 92%.
         Embodiment 2
 5       The reaction vessel were added 3 mol 2-hydroxy-3-ethyl-4-aminopyridine and
   6 .5mol ethylene glycol monobutyl ether with a mass fraction of 83%, controlled the
   stirring speed at 180 rpm, raised the solution temperature to 65 'C, and then added 3.5
   mol triethyl antimony 4 times, raised the temperature of the solution to 77 C for 60 min,
   precipitated the solid, washed with the potassium bromide solution with a mass fraction
10 of 23% in 7 times, combined filtrate and washing liquid, added the oxalic acid solution
   with a mass fraction of 32% to adjust the pH to 2.5, reduced the solution temperature to
   7 C, precipitated the solid, washed with the N-dimethyl acetamide solution with a
   mass fraction of 73%, washed with the dimethyl amine solution with a mass fraction of
   87%, recrystallizated in the p-cresol solution with a mass fraction of 93%, dehydrated
15 with dehydration, got the finished pyridine-3-carboxylic acid 346.86g, yield 94%.
         Embodiment 3
         The reaction vessel were added 3 mol 2-hydroxy-3-ethyl-4-aminopyridine and
   7mol ethylene glycol monobutyl ether with a mass fraction of 87%, controlled the
20 stirring speed at 190 rpm, raised the solution temperature to 70 'C, and then added 4
   mol triethyl antimony 6 times, raised the temperature of the solution to 80'C for 70 min,
   precipitated the solid, washed with the potassium bromide solution with a mass fraction
   of 26% in 9 times, combined filtrate and washing liquid, added the oxalic acid solution
   with a mass fraction of 35% to adjust the pH to 3, reduced the solution temperature to
25 9 C, precipitated the solid, washed with the N-dimethyl acetamide solution with a
   mass fraction of 77%, washed with the dimethyl amine solution with a mass fraction of
   91%, recrystallizated in the p-cresol solution with a mass fraction of 96%, dehydrated
   with dehydration, got the finished pyridine-3-carboxylic acid 357.93g, yield 97%.

                                                 4
         Claims
         1. Vitamin medicine pyridine-3-formic acid synthesis method, comprises the
   following steps:
 5       (i) 3 mol 2-hydroxy-3-ethyl-4-aminopyridine       and 6-7 mol ethylene glycol
   monobutyl ether were added to the reaction vessel, controlled the stirring speed of
   170-190 rpm, raised the temperature of the solution to 60-70 "C, then added 3-4 mol
   of triethyl antimony in 3-6 times, raised the temperature of the solution to 75-80 0C,
   kept for 50-70 min, precipitated the solid, washed with potassium bromide solution in
10 6-9 times, merged the filtrate and the washing liquid, the oxalic acid solution was
   added to adjust the pH to 2-3, the solution temperature is reduced to 5-9 "C, the solid
   is precipitated, washed with N-dimethylacetamide solution, and washed with the
   dimethylamine solution, recrystallized in p-cresol solution; wherein, the mass fraction
   of the ethylene glycol monobutyl ether solution in step (i) is        8 0 -8 7 % and the mass
15 fraction of the potassium bromide described in step (i) is 20-26%, the mass fraction
   of the oxalic acid solution in step (i)       is 30-35%, the mass fraction of the
   N-dimethylacetamide solution in step (i) is 70 to 77%.
         2. Vitamin medicine pyridine-3-formic acid synthesis method according to claim
20 1 wherein the mass fraction of the dimethylamine solution described in step (i) is 85
   to 91%.
         3. Vitamin medicine pyridine-3-formic acid synthesis method according to claim
   1 wherein the mass fraction of p-cresol solution in step (i) is 9 0 - 9 6 %.

